Risiken und Komplikationen implantierter Kathetersysteme

Zusammenfassung

Implantierte Portkatheter stellen ein wertvolles Hilfsmittel in der Behandlung onkologischer Patienten dar. Leider sind sie mit nicht zu unterschätzenden Risiken und Komplikationen wie Infektion, Thrombose, Embolie, Okklusion oder Dislokation verbunden. Nur das Wissen um mögliche Komplikationen und ein sachgerechter Umgang kann das mit diesen Portkathetersystemen zusammenhängende Risiko minimieren.

Summary

Implanted port catheters are an effective and very helpful tool in the management of cancer patients. This usage of these catheter systems is associated with minor, but definite risks like port occlusion, dislocation, thrombosis, embolism and infection. Careful management and care of these devices as well as a perfect knowledge of possible complications is the basis for an effective risk reduction.

Schlüsselwörter

Portinfektion - Portokklusion - palliative Chemotherapie - parenterale Ernährung

Keywords

port associated infections - occlusion of portcatheter - palliative chemotherapy - total parenteral nutrition

Literatur

• 01 Anderson A J, Krasnow S H, Boyer M W. et al . Thrombosis: The major Hickman catheter complication in patients with solid tumor.  Chest. 1989;  95 71-75
• 02 Au F C, Badellino M. Significance of a curled central venous catheter tip.  Chest. 1988;  93 890-891
• 03 Bagnall H A, Gomperts E, Atkinson J B. Continuous infusion of low-dose urokinase in the treatment of central venous catheter thrombosis in infants and children.  Pediatrics. 1989;  83 963-966
• 04 Bagnall-Reeb H A, Ruccione K. Management of cutaneous reactions and mechanical complications of central venous access devices in pediatric patients with cancer: Algorithms for decision making.  Oncol Nurs Forum. 1990;  17 677-681
• 05 Beers T R, Burnes J, Fleming C R. Superior vena cava obstruction in patients with gut failure receiving home parenteral nutrition.  JPEN. 1990;  14 474-479
• 06 Benezra D, Kiehn T, Gold J W M. et al . Prospective study of infections in indwelling central venous catheters using quanitative blood cultures.  Am J Med. 1988;  85 495-498
• 07 Bern M M, Lokich J J, Wallach S R. et al . Very low doses of warfarin can prevent thrombosis in central venous catheters.  Ann Intern Med. 1990;  112 423-428
• 08 Breaux C W, Duke D, Georgeson K E. et al . Calcium phosphate crystal occlusion of central venous catheters used for total parenteral nutrition in infants and children: Prevention and treatment.  J Pediatr Surg. 1987;  22 829-832
• 09 Brothers T E, Moll von L K, Niederhuber J E. et al . Experience with subcutaneous infusion ports in three hundred patients.  Surg Gynecol Obstet. 1988;  166 295-301
• 10 Brown-Smith J K, Stoner M H, Barley Z A. Tunneled catheter thrombosis: Factors related to incidence.  Oncol Nurs Forum. 1990;  17 543-549
• 11 Camp-Sorrell D. Advanced central venous access. Selection, catheters, devices, and nursing management.  J Intravenous Nurs. 1990;  13 361-370
• 12 Carde P, Cosset-Delaigue M F, LaPlanche A. et al . Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: A randomized trial in 100 patients with solid tumors.  Eur J Cancer Clin Oncol. 1989;  25 939-944
• 13 Cathcart-Rake W F, Mowery W E. Intrapericardial infusion of 5-fluorouracil. An unusual complication of a Hickman catheter.  Cancer. 1991;  67 735-737
• 14 Cervera M, Dolz M, Herraez J V. et al . Evaluation of the elastic behaviour of central venous PVC, polyurethane and silicone catheters.  Phys Med Biol. 1989;  34 177-183
• 15 Chakravarthy A, Edwards W D, Fleming C R. Fatal tricuspid valve obstruction due to a large infected thrombus attached to a Hickman catheter.  JAMA. 1987;  257 801-803
• 16 Clarke D E, Raffin T A. Infectious complications of indwelling long-term central venous catheters.  Chest. 1990;  97 966-972
• 17 Conly J M, Grieves K, Peters B. A prospective, randomized study comparing transparent and dry gauze dressings for central venous catheters.  J Infect Dis. 1989;  159 310-319
• 18 Gregorio  de M A, Miguelena J M, Fernandez J A. et al . Subcutaneous ports in the radiology suite: an effective and safe procedure for care in cancer patients.  Eur Radiol. 1996;  6 (5) 748-52
• 19 Dickman J, Ransom J. Extravasation of doxorubicin from a Hickman catheter: A case presentation.  Oncol Nurs Forum. 1985;  12 (6) 50-52
• 20 Duffy L F, Kerzner B, Gebus V. et al . Treatment of central venous catheter occlusions with hydrochloric acid.  J Pediatr. 1989;  114 1002-1004
• 21 Early T F, Gregory R T, Wheeler J R. et al . Increased infection rate in double-lumen versus single-lumen Hickman catheters in cancer patients.  South Med. 1990;  83 34-36
• 22 Ellis L M, Vogel S B, Copeland E M. Central venous catheter vascular erosions. Diagnosis and clinical course.  Ann Surg. 1989;  209 475-478
• 23 Faubion W C, Wesley J R, Khalidi N. et al . Total parenteral nutrition catheter sepsis: Impact of the team approach.  Parenter Enteral Nutr. 1986;  10 642-645
• 24 Flowers III R H, Schwenzer K J, Kopel R F. et al . Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection.  JAMA. 1989;  261 878-88
• 25 Flynn P M, Shenep J L, Stokes D C. et al . In situ management of confirmed central venous catheter-related bacteremia.  Pediatr Infec Dis J. 1987;  6 729-734
• 26 Franey T, DeMarco L C, Geiss A C. et al . Catheter fracture and embolization in a totally implanted venous access catheter.  JPEN. 1988;  12 528-530
• 27 Fraschini G, Jadeja J, Lawson M. et al . Local infusion of urokinase for the lysis of thrombosis associated with permanent central venous catheters in cancer patients.  J Clin Oncol. 1987;  5 672-678
• 28 Fuchs P C, Gustafson M E, King J T. et al . Assessment of catheter-associated infection risk with the Hickman right atrial catheter.  Infect Control. 1984;  5 226-230
• 29 Gaillard J L, Merlino R, Pajot N. et al . Conventional and nonconventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci.  J Parenteral Enteral Nutr. 1990;  14 593-597
• 30 Gemlo B T, Rayner A A, Swanson R J. et al . Extravasation. A serious complication of the split-sheath introducer technique for venous access.  Arch Surg. 1988;  123 490-492
• 31 Gray W J, Bell W R. Fibrinolytic agents in the treatment of thrombotic disorders.  Semin Oncol. 1990;  17 228-237
• 32 Gucalp R. Management of the febrile neutropenic patient with cancer.  Oncology. 1991;  5 (7) 137-148
• 33 Hadaway L C. Evaluation and use of advanced IV technology. Part 1: Central venous access devices.  J Intravenous Nurs. 1989;  12 73-83
• 34 Haire W D, Lieberman R P, Edney J. et al . Hickman catheter-induced thoracic vein thrombosis.  Cancer. 1990;  66 900-908
• 35 Hartman G E, Shochat S J. Management of septic complications associated with silastic catheters in childhood malignancy.  Pediatr Infec Dis J. 1987;  6 1042-1047
• 36 Hiemenz J, Skelton J, Pizzo P A. Perspective on the management of catheter-related infections in cancer patients.  Pediatr Infect Dis J. 1986;  5 6-11
• 37 Hughes W T, Bodey G P, Meyers J D. et al . Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.  J Infec Dis. 1990;  161 381-396
• 38 Jones P M. Indwelling central venous catheter-related infections and two different procedures of catheter care.  Cancer Nurs. 1987;  10 123-130
• 39 Kappers-Klunne M C, Degener J E, Stijnen T. et al . Complications from long-term venous catheters in hematologic patients with special reference to infection.  Cancer. 1989;  64 1747-1752
• 40 Kirvela O, Satokari K. In situ breakage of a totally implanted venous access system.  JPEN. 1989;  13 99-101
• 41 Lambert M E, Chadwick G A, McMahon A. et al . Experience with the portacath.  Hematol Oncol. 1988;  6 57-63
• 42 Lawson M, Bottino J C, Hurtubise M R. et al . The use of urokinase to restore the patency of occluded central venous catheters.  Am J IV Ther Clin Nutr. 1982;  9 (9) 29-32
• 43 Leibovitz E, Ashkenazi A, Levin S. et al . Fatal pericardial tamponade complicating total parenteral nutrition via a silastic central vein catheter.  J Pediatr Gastroenteral Nutr. 1988;  7 306-307
• 44 Levine M, Hirsh J. The diagnosis and treatment of thrombosis in the cancer patient.  Semin Oncol. 1990;  17 160-171
• 45 Levine M N, Gent M, Hirsh J. et al . The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer.  N Engl J Med. 1988;  318 404-407
• 46 Lim S P. Recurrent secondary displacement of long-term indwelling silastic atrial catheters.  South Med J. 1987;  80 1420-1424
• 47 Lokich J J, Becker B. Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy.  Cancer. 1983;  52 1586-1589
• 48 Lokich J J, Moore C. Drug extravasation in cancer chemotherapy.  Ann Intern Med. 1986;  104 124
• 49 Maki D G, Cobb L, Garman J K. et al . An attachable silver-impregnated cuff for prevention of infection with central venous catheters: A prospective randomized multicenter trial.  Am J Med. 1988;  85 307-314
• 50 McCarthy M C, Shives J K, Robison R J. et al . Prospective evaluation of single and triple lumen catheters in total parenteral nutrition.  J Parenter Enteral Nutr. 1987;  11 259-262
• 51 Moss J F, Wagman L D, Riihimaki D U. et al . Central venous thrombosis related to the silastic Hickman-Broviac catheter in an oncologic population.  J Parenter Enteral Nutr. 1989;  13 397-400
• 52 Müller H, Gallkowski U, Manekeller S. et al . Umgang mit und Pflege von implantierten Portkathetern bei Tumorpatienten - ein interdisziplinäres Problem.  Integrative Onkologie. 2004;  1 34-36
• 53 Nelson D B, Kien c L, Mohr B. et al . Dressing changes by specialized personnel reduce infection rates in patients receiving central venous parenteral nutrition.  JPEN. 1986;  10 220-222
• 54 Pemberton L B, Lyman B, Lander V. et al . Sepsis from triple vs. single-lumen catheters during total parenteral nutrition in surgical or critically ill patients.  Arch Surg. 1986;  121 591-594
• 55 Pennington C R, Pithie A D. Ethanol lock in the management of catheter occlusion.  JPEN. 1987;  11 507-508
• 56 Peters G, Locci R, Pulverer G. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters.  J Infect Dis. 1982;  146 479-482
• 57 Prager D, Hertzberg R W. Spontaneous intravenous catheter fracture and embolization from an implanted venous access port and analysis by scanning electron microscopy.  Cancer. 1987;  60 270-273
• 58 Quie P G, Belani K K. Coagulase-negative staphylococcal adherence and persistence.  J Infec Dis. 1987;  156 543-547
• 59 Rauthe G, Altmann C. Venous port systems in the field of gynaecological oncology.  Eur J Gynaecol Oncol. 1998;  19 (2) 173-8
• 60 Reed W P, Newman K A, Tenney J H. et al . Autopsy findings after prolonged catheterization of the right atrium for chemotherapy in acute leukemia.  Surg Gynecol Obstet. 1985;  160 417-420
• 61 Rubenstein R B, Alberty R E, Michels L G. et al . Hickman catheter separation.  JPEN. 1985;  9 754-757
• 62 Rudolph R, Larson D L. Etiology and treatment of chemotherapeutic agent extravasation injuries: A review.  J Clin Oncol. 1987;  5 1116-1126
• 63 Rupar D G, Herzog K D, Fisher M C. et al . Prolonged bacteremia with catheter-related central venous thrombosis.  Am J Dis Child. 1990;  144 879-882
• 64 Schulman R F, Reed T, Pitre D. et al . Use of hydrochloric acid to clear obstructed central venous catheters.  JPEN. 1988;  12 509-510
• 65 Schulmeister L. Needle dislodgement from implanted venous access devices: Inpatient and outpatient experiences.  J Intravenous Nurs. 1989;  12 90-92
• 66 Schuman E S, Winters V, Gross G F. et al . Management of Hickman catheter sepsis.  Am J Surg. 1985;  149 627-628
• 67 Schwartz C, Henrickson K J, Roghmann K. et al . Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms.  J Clin Oncol. 1990;  8 1591-1597
• 68 Scott W L. Complications associated with central venous catheters. A survey.  Chest. 1988;  94 1221-1224
• 69 Smith N L, Ravo B, Soroff H S. et al . Successful fibrinolytic therapy for superior vena cava thrombosis secondary to long-term total parenteral nutrition.  JPEN. 1985;  9 55-57
• 70 Strum S B, McDermed J E. Drug extravasation and the Port-a-Cath system.  Ann Intern Med. 1985;  103 472-473
• 71 Taber S W, Bergamini T M. Long-term venous access: indications and choice of site and catheter.  Semin Vasc Surg. 1997;  10 (3) 130-4
• 72 Tocino I M, Watanabe A. Impending catheter perforation of superior vena cava: Radiographic recognition.  AJR. 1986;  146 487-490
• 73 Ulz L, Petersen F B, Ford R. et al . A prospective study of complications in Hickman right-atrial catheters in marrow transplant patients.  J Parenter Enteral Nutr. 1990;  14 27-30
• 74 Watterson J, Heisel M, Cich J A. et al . Intrathoracic extravasation of sclerosing agents associated with central venous catheters.  Am J Pediatr Hematol Oncol. 1988;  10 249-251
• 75 Wickham R. Extravasation from venous access devices.  Outpatient Chemotherapy. 1989;  3 (4) 3-10
• 76 Williams E C. Catheter-related thrombosis.  Clin Cardiol. 1990;  13 V134-V136
• 77 Wurzel C L, Halom K, Feldman J G. et al . Infection rates of Broviac-Hickman catheters and implantable venous devices.  Am J Dis Child. 1988;  142 536-540

Korrespondenzadresse